Skip to content

Clinical trials

Phase 2 Central Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Phase: Phase 2 Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20074
20083
20094
20104
20114
20122
20132
20141
20151
20162
20176
20186
20192
20203
20214
20224
20235
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Recruiting8
Withdrawn6
Terminated5
Active, not recruiting3
Unknown status3
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis5
MapLight Therapeutics4
Alkahest, Inc.3
Inmune Bio, Inc.3
Neuroscience Trials Australia3
Northwestern University3
FORUM Pharmaceuticals Inc2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
National Institute of Allergy and Infectious Diseases (NIAID)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases69
Brain Diseases41
Nervous System Diseases41
Neurodegenerative Diseases29
Alzheimer Disease21
Mental Disorders20
Dementia19
Neurocognitive Disorders13
Movement Disorders11
Parkinson Disease10

Trials

Showing 76 to 69 of 69. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.